---
title: "Projected Estimates of Cancer in Canada in 2026"
id: "cmaj-0-projected-estimates-of-cancer-in-canada-in-2026-research-"
canonical_url: "https://medichelpline.com/clinical-feed/cmaj-0-projected-estimates-of-cancer-in-canada-in-2026-research-"
content_type: "clinical_feed_article"
specialty: "Research Highlights"
source_name: "CMAJ"
source_url: "http://www.cmaj.ca/cgi/content/short/198/14/E526?rss=1"
published_at: "2026-04-13T04:05:27.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Projected Estimates of Cancer in Canada in 2026
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/cmaj-0-projected-estimates-of-cancer-in-canada-in-2026-research-
- **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md)
- **Primary Source:** CMAJ
- **Source URL:** [Original Journal Publication](http://www.cmaj.ca/cgi/content/short/198/14/E526?rss=1)
- **Published At:** 2026-04-13T04:05:27.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
Background: Cancer is the leading cause of death and has major health and economic impacts on people in Canada. We sought to provide updated estimates of cancer incidence and mortality to highlight progress and areas of need for planning and awareness. Methods: We estimated cases, deaths, and age-standardized incidence (ASIR) and mortality rates (ASMR) in 2026, standardized to the 2021 Canadian standard population, by sex and province or territory. We used data from the Canadian Cancer Registry (until 2022) and the Canadian Vital Statistics Death Database (until 2023). We modelled incidence and mortality with the canproj projection package. Results: In Canada, an estimated 254 100 people will be diagnosed with cancer and 87 900 will die from cancer in 2026. Overall, the ASIR (591.4 per 100 000) and the ASMR (200.0 per 100 000) are projected to decrease from previous years. Lung, breast, prostate, and colorectal cancers are projected to account for 47% of all new cases. The ASIR for all cancers combined is anticipated to be 16% higher among males than females (642.2 v.
## Clinical Analysis & Structured Key Points
CMAJ published a clinical update in Research Highlights on 13 Apr 2026. The item focuses on Projected estimates of cancer in Canada in 2026 [Research]. Review the original article for the full source wording and details.
## Related Clinical Research

- [Modelling the impact of mosquito bed net utilization on malaria transmission and evolution of pyrethroid resistance](https://medichelpline.com/clinical-feed/plos-one-23-modelling-the-impact-of-mosquito-bed-net-utilization-on-malaria-transmission.md)
- [Maternal knowledge of obstetric danger signs and related factors among antenatal care attendees in Hargeisa, Somaliland: A cross-sectional analysis](https://medichelpline.com/clinical-feed/plos-one-7-maternal-knowledge-of-obstetric-danger-signs-and-related-factors-among.md)
- [Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study](https://medichelpline.com/clinical-feed/plos-medicine-0-self-explaining-artificial-intelligence-for-the-classification-of-b-cell-non.md)
- [New study maps how 12 modifiable dementia risks differ around the world](https://medichelpline.com/clinical-feed/medical-news-today-0-new-study-maps-how-12-modifiable-dementia-risks-differ-around-the-world.md)
- [Eating an avocado a day may lower cholesterol in adults with obesity](https://medichelpline.com/clinical-feed/medical-news-today-1-eating-an-avocado-a-day-may-lower-cholesterol-in-adults-with-obesity.md)

## Navigation
- [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.